Instrument Inactif

Communiqués Propanc Biopharma Inc Other OTC

Actions

US74346N1072

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Propanc Biopharma Receives Certificate of Grant for Proenzymes Composition Patent from Japanese Patent Office	26/06	AQ
Propanc Biopharma : Material Agreement - Form 8-K	22/04	PU
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office	17/04	AQ
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing	09/04	AQ
Propanc Biopharma : Material Agreement - Form 8-K	11/03	PU
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study	23/02	AQ
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP	14/12	AQ
Propanc Biopharma Peer Reviewed Scientific Article Reaches 3,000 Reads	14/07/23	AQ
Propanc Biopharma : Material Agreement - Form 8-K	12/07/23	PU
Propanc Biopharma Provides Shareholder Update - June 22, 2023	23/06/23	AQ
Propanc Biopharma Provides Shareholder Update	23/06/23	AQ
PROPANC BIOPHARMA, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	05/05/23	AQ
Propanc Biopharma Announces That PRP Suppresses TGF- Pathway and Tumor Microenvironment in Pancreatic Cancer	29/03/23	AQ
PROPANC BIOPHARMA, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	17/03/23	AQ
Propanc Biopharma Confirms PRP Exerts Significant Effects against Chemoresistant Pancreatic Tumor Cells	17/03/23	AQ
PROPANC BIOPHARMA, INC. : Other Events (form 8-K)	22/02/23	AQ
PROPANC BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	21/02/23	AQ
PROPANC BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/02/23	AQ
Propanc Biopharma's Joint Researcher Receives Award at Doctoral Conference at the University of Jaen	16/12/22	AQ
Propanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic Cancer	01/12/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Propanc Biopharma Inc Other OTC

Actions

US74346N1072

Communiqués

Filtres